What does CUSIP 45259L304 represent in this 13F holders report?

CUSIP 45259L304 is the security identifier for IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK in Q3 2026?

2 institutional investors reported IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK for Q3 2026. Use the holders table for investor-level position and value details.

IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO)

CUSIP: 45259L304

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / COMMON STOCK
Total 13F shares: 151
Total 13F value: $845
Share change: +151
SEC-reported price per share: $5.58
Number of holders: 2
Value change: +$845
Number of buys: 2

Security key

45259L304

Report period

Q3 2026

Institutions

Top holders

IBO full security history Ownership snapshot Full 13F holder table IMPACT BIOMEDICAL INC. SEC filings IMPACT BIOMEDICAL INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 45259L304

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Heng Fai Ambrose Chan

Disclosed value leader

GEODE CAPITAL MANAGEMENT,...

Comparable rows

1/15

Latest evidence

22 Sep 2026

13D/G 3/4/5 13F Lead comparable stake: 2.9% 14 rows are not safely comparable across share classes. 13D/G row: Heng Fai Ambrose Chan Showing 1-6 of 15 holder rows.

Quick read

Heng Fai Ambrose Chan leads the comparable SEC ownership view at 2.9%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Heng Fai Ambrose Chan's linked filing trail.

Comparable ownership Top 1

Heng Fai Ambrose Chan 2.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Heng Fai Ambrose Chan	13D/G 13D/G	2.9% Reported 13D/G · 02 Apr 2025	— 351,555 shares	$0	02 Apr 2025
DSS, INC.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$271,178 589,518 shares	-$398	22 Sep 2026
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$545,578 1,185,163 shares	—	30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC	13F Company 13F	— denominator unverified	$371,997 808,689 shares	—	30 Jun 2026
STATE STREET CORP	13F Company 13F	— denominator unverified	$279,633 607,897 shares	—	30 Jun 2026
VANGUARD FIDUCIARY TRUST CO	13F Company 13F	— denominator unverified	$271,137 589,428 shares	—	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

151

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

Q3 2026 holders

Holder diff

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend